{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:53:15Z","timestamp":1760028795846},"reference-count":25,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2009,8,3]],"date-time":"2009-08-03T00:00:00Z","timestamp":1249257600000},"content-version":"vor","delay-in-days":6211,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Internal Medicine"],"published-print":{"date-parts":[[1992,8]]},"abstract":"<jats:p>Dexfenfluramine, an effective and safe serotoninergic drug with anorectic and possible food\u2010selection\u2010tuning properties, was investigated in a placebo\u2010controlled study of 1 year's duration in severe and refractory obesity. The aim of the study was to assess weight loss, and changes in cardiovascular risk factors, food intake and eating behaviour. Dexfenfluramine\u2010 and placebo\u2010treated patients achieved a similar weight loss (&gt; 10% of initial weight, by 39.5 and 30.0%, &gt; 20% of initial overweight by 42.1% and 32.5% and &gt; 10 kg by 41.4 and 33.3%, respectively, of the initial cohorts). Furthermore, the decreases in weight (10.7 vs. 8.0 kg), in body mass index (3.9 vs. 2.9 kg m<jats:sup>\u22122<\/jats:sup>) and in waist\/hip ratio (0.04 vs. 0.02) were not significantly different. After discontinuation of the drug, the increase in weight (2.8 vs. 1.0 kg) was significantly higher in the dexfenfluramine\u2010treated group. Except for a borderline better effect on glucose of dexfenfluramine, both groups showed similar beneficial changes in food intake and cardiovascular risk factors. Eating behaviour in response to emotional and external stimuli was comparable in the two groups, but placebo\u2010treated patients had to restrain their eating more in order to achieve the same weight loss. Notwithstanding the fact that weight losses and an associated amelioration of health\u2010risk factors were of similar magnitude in dexfenfluramine\u2010 and placebo\u2010treated patients, dexfenfluramine might have a useful role in promoting a less stressed adherence to prolonged restriction of energy intake in the severe and refractory obese subject.<\/jats:p>","DOI":"10.1111\/j.1365-2796.1992.tb00560.x","type":"journal-article","created":{"date-parts":[[2009,8,3]],"date-time":"2009-08-03T13:59:09Z","timestamp":1249307949000},"page":"119-127","source":"Crossref","is-referenced-by-count":34,"title":["Dexfenfluramine in the treatment of severe obesity: a placebo\u2010controlled investigation of the effects on weight loss, cardiovascular risk factors, food intake and eating behaviour"],"prefix":"10.1111","volume":"232","author":[{"given":"E. M. H.","family":"MATHUS\u2010VLIEGEN","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"VAN, de VOORDE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. M. E.","family":"KOK","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. M. A.","family":"RES","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,8,3]]},"reference":[{"key":"e_1_2_2_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(89)91499-2"},{"key":"e_1_2_2_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/0091-3057(82)90164-2"},{"key":"e_1_2_2_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(84)90101-2"},{"issue":"1","key":"e_1_2_2_5_2","first-page":"S33","article-title":"Dexfenfluramine: effects on food intake in various animal models","volume":"11","author":"Rowland NE","year":"1988","journal-title":"Clin Neuropharmacol"},{"key":"e_1_2_2_6_2","doi-asserted-by":"publisher","DOI":"10.1002\/1098-108X(198123)1:1<2::AID-EAT2260010102>3.0.CO;2-Q"},{"key":"e_1_2_2_7_2","first-page":"79","article-title":"d\u2010Fenfluramine selectively decreases carbohydrate but not protein intake in obese subjects","volume":"1","author":"Wurtman JJ","year":"1983","journal-title":"Int Monogr Obes Series"},{"key":"e_1_2_2_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0195-6663(86)80055-1"},{"key":"e_1_2_2_9_2","doi-asserted-by":"publisher","DOI":"10.1002\/1098-108X(198711)6:6<687::AID-EAT2260060602>3.0.CO;2-O"},{"key":"e_1_2_2_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0195-6663(86)80057-5"},{"key":"e_1_2_2_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/0031-9384(80)90153-5"},{"key":"e_1_2_2_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/0031-9384(84)90127-6"},{"key":"e_1_2_2_13_2","first-page":"247","volume-title":"Body Weight Control","author":"Fantino M.","year":"1987"},{"key":"e_1_2_2_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(82)90445-3"},{"key":"e_1_2_2_15_2","doi-asserted-by":"publisher","DOI":"10.1038\/229125a0"},{"key":"e_1_2_2_16_2","first-page":"207","volume-title":"Metabolic Complications of Human Obesities","author":"Brindley DN","year":"1985"},{"key":"e_1_2_2_17_2","first-page":"87","volume-title":"Eating and Its Disorders","author":"Keesey RE","year":"1984"},{"key":"e_1_2_2_18_2","first-page":"97","volume-title":"Eating and Its Disorders","author":"Faust IM","year":"1984"},{"key":"e_1_2_2_19_2","first-page":"785","article-title":"En f\u00d6r alia: \u00c9\u00c9n bloeddrukmanchet voor allen: een aanbeveling","volume":"132","author":"Mathus\u2010Vliegen EMH","year":"1988","journal-title":"Ned Tijdschr Geneeskd"},{"key":"e_1_2_2_20_2","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/1098-108X(198602)5:2<295::AID-EAT2260050209>3.0.CO;2-T","article-title":"The Dutch Eating Behaviour Questionnaire (DEBQ) for assessment of restrained emotional and external eating behaviour","volume":"5","author":"Strien T.","year":"1986","journal-title":"Int J Eat Dis"},{"key":"e_1_2_2_21_2","first-page":"10","article-title":"The surgical treatment of morbid obesity","volume":"21","author":"Carey LC","year":"1984","journal-title":"Curr Prosp Surg"},{"key":"e_1_2_2_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(84)90209-9"},{"key":"e_1_2_2_23_2","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.1800770127"},{"key":"e_1_2_2_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(90)91017-Z"},{"key":"e_1_2_2_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0195-6663(86)80059-9"},{"key":"e_1_2_2_26_2","first-page":"285","volume-title":"Recent Advances in Obesity Research. V","author":"Silverstone T.","year":"1986"}],"container-title":["Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2796.1992.tb00560.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2796.1992.tb00560.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,23]],"date-time":"2023-10-23T20:06:14Z","timestamp":1698091574000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2796.1992.tb00560.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1992,8]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1992,8]]}},"alternative-id":["10.1111\/j.1365-2796.1992.tb00560.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2796.1992.tb00560.x","archive":["Portico"],"relation":{},"ISSN":["0954-6820","1365-2796"],"issn-type":[{"type":"print","value":"0954-6820"},{"type":"electronic","value":"1365-2796"}],"subject":[],"published":{"date-parts":[[1992,8]]}}}